Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castrat... by Gundram Jung, Jonas S Heitmann, Juliane S Walz, Martin Pflügler, Joseph Kauer, Richard F Schlenk, Helmut R Salih

Get full text

Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies by Melanie Märklin, Gundram Jung, Jonas S Heitmann, Helmut R Salih, Martina Svenja Lutz, Boris Klimovich, Stefanie Maurer, Latifa Zekri, Clemens Hinterleitner

Get full text

Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies by Hans-Georg Rammensee, Melanie Märklin, Gundram Jung, Jonas S Heitmann, Joseph Kauer, Helmut R Salih, Latifa Zekri, Lukas Osburg, Sebastian Hörner, Stefanie Müller

Get full text

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients by Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Susanne Jung, Susanne Jung, Susanne Jung, Marcel Wacker, Marcel Wacker, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Jens Bauer, Jens Bauer, Jens Bauer, Monika Denk, Monika Denk, Monika Denk, Naomi Hoenisch-Gravel, Naomi Hoenisch-Gravel, Marion Richter, Marion Richter, Marion Richter, Melek T. Oezbek, Melek T. Oezbek, Marissa L. Dubbelaar, Marissa L. Dubbelaar, Marissa L. Dubbelaar, Marissa L. Dubbelaar, Tatjana Bilich, Tatjana Bilich, Tatjana Bilich, Marina Pumptow, Peter Martus, Gerald Illerhaus, Claudio Denzlinger, Francesca Steinbach, Walter-Erich Aulitzky, Martin R. Müller, Daniela Dörfel, Hans–Georg Rammensee, Hans–Georg Rammensee, Hans–Georg Rammensee, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz

Get full text